Showing results (101-110 of 367) with videos related to
Sort By:
Pageof 37
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1993
Sulphatide antigen in islets of Langerhans and in diabetic glomeruli, and anti-sulphatide antibodies in type 1 diabetes mellitusK Buschard, K Josefsen, T Horn, et al.British Journal of Anaesthesia|June 1, 1990
Effect of major surgery on absorption rate of NPH insulin injected s.cA Hjortrup, S Madsbad, M Andersen, et al.Acta Anaesthesiologica Scandinavica|December 1, 1984
Evaluation of two methods of rapid blood-glucose monitoring by unskilled personnel during surgeryS Madsbad, B Adelhøj, D Bigler, et al.Diabetes|May 1, 1996
The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormonesM Toft-Nielson, S Madsbad, J J HolstInternational Journal of Clinical Practice|November 21, 2009
Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over timeB Gallwitz, A Vaag, A Falahati, et al.Acta Endocrinologica|May 1, 1987
Effect of sham-feeding on glucose tolerance and insulin secretionM Lorentzen, S Madsbad, H Kehlet, et al.Journal of Endocrinological Investigation|February 1, 1986
Rapid changes in plasma androgens during insulin withdrawal in male type 1 (insulin-dependent) diabeticsS Madsbad, C Gluud, P Bennett, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|March 16, 2011
Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potentialS S Torekov, S Madsbad, J J HolstDiabetes|May 1, 1983
Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucoseS Madsbad, H Kehlet, J Hilsted, et al.Diabetologia|October 30, 1998
Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemiaM Toft-Nielsen, S Madsbad, J J HolstPageof 37